48 related articles for article (PubMed ID: 23954573)
1. Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.
Soler DC; Sugiyama H; Young AB; Massari JV; McCormick TS; Cooper KD
Clin Immunol; 2013 Oct; 149(1):111-8. PubMed ID: 23954573
[TBL] [Abstract][Full Text] [Related]
2. C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke.
Li P; Wang L; Zhou Y; Gan Y; Zhu W; Xia Y; Jiang X; Watkins S; Vazquez A; Thomson AW; Chen J; Yu W; Hu X
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28768648
[TBL] [Abstract][Full Text] [Related]
3. Role of regulatory T cells in psoriasis pathogenesis and treatment.
Nussbaum L; Chen YL; Ogg GS
Br J Dermatol; 2021 Jan; 184(1):14-24. PubMed ID: 32628773
[TBL] [Abstract][Full Text] [Related]
4. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature.
Mattozzi C; Salvi M; D'Epiro S; Giancristoforo S; Macaluso L; Luci C; Lal K; Calvieri S; Richetta AG
Dermatology; 2013; 227(2):134-45. PubMed ID: 24051528
[TBL] [Abstract][Full Text] [Related]
5. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.
Teunissen MBM; Munneke JM; Bernink JH; Spuls PI; Res PCM; Te Velde A; Cheuk S; Brouwer MWD; Menting SP; Eidsmo L; Spits H; Hazenberg MD; Mjösberg J
J Invest Dermatol; 2014 Sep; 134(9):2351-2360. PubMed ID: 24658504
[TBL] [Abstract][Full Text] [Related]
6. IL-33 is regulated by TNF-α in normal and psoriatic skin.
Balato A; Di Caprio R; Canta L; Mattii M; Lembo S; Raimondo A; Schiattarella M; Balato N; Ayala F
Arch Dermatol Res; 2014 Apr; 306(3):299-304. PubMed ID: 24522896
[TBL] [Abstract][Full Text] [Related]
7. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
[TBL] [Abstract][Full Text] [Related]
8. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
[TBL] [Abstract][Full Text] [Related]
9. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris.
Zhao M; Wang LT; Liang GP; Zhang P; Deng XJ; Tang Q; Zhai HY; Chang CC; Su YW; Lu QJ
Clin Immunol; 2014 Jan; 150(1):22-30. PubMed ID: 24316592
[TBL] [Abstract][Full Text] [Related]
11. Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production.
He X; Koenen HJPM; Smeets RL; Keijsers R; van Rijssen E; Koerber A; van de Kerkhof PC; Boots AMH; Joosten I
J Invest Dermatol; 2014 Apr; 134(4):975-983. PubMed ID: 24192715
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors.
Wan Z; Huang J; Ou X; Lou S; Wan J; Shen Z
An Bras Dermatol; 2024; 99(3):425-432. PubMed ID: 38388337
[TBL] [Abstract][Full Text] [Related]
13. High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property.
Lee BH; Bang YJ; Lim SH; Kang SJ; Kim SH; Kim-Schulze S; Park CG; Kim HJ; Kim TG
EBioMedicine; 2024 Feb; 100():104985. PubMed ID: 38306895
[TBL] [Abstract][Full Text] [Related]
14. Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review.
Wu M; Dai C; Zeng F
Clin Cosmet Investig Dermatol; 2023; 16():2503-2515. PubMed ID: 37727872
[TBL] [Abstract][Full Text] [Related]
15. Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?
Pietraforte I; Frasca L
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901778
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis: Mechanism and connections with cutaneous diseases.
Liu L; Lian N; Shi L; Hao Z; Chen K
Front Cell Dev Biol; 2022; 10():1079548. PubMed ID: 36684424
[TBL] [Abstract][Full Text] [Related]
17. 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk.
Liu N; Sadlon T; Wong YY; Pederson S; Breen J; Barry SC
Epigenetics Chromatin; 2022 Jun; 15(1):24. PubMed ID: 35773720
[TBL] [Abstract][Full Text] [Related]
18. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).
Soler DC; Kerstetter-Fogle A; Young AB; Rayman P; Finke JH; Debanne SM; Cooper KD; Barnholtz-Sloan J; Sloan AE; McCormick TS
Mol Immunol; 2022 Feb; 142():1-10. PubMed ID: 34953280
[TBL] [Abstract][Full Text] [Related]
19. Potential Therapeutic Approaches through Modulating the Autophagy Process for Skin Barrier Dysfunction.
Choi MS; Chae YJ; Choi JW; Chang JE
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360634
[TBL] [Abstract][Full Text] [Related]
20. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
Selck C; Dominguez-Villar M
Front Immunol; 2021; 12():661875. PubMed ID: 34054826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
